PFM Health Sciences’s Nightstar Therapeutics plc American Depositary Shares NITE Stock Holding History

PFM Health Sciences’s Portfolio NITE Stock Details NITE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-1,016,980	Closed	-$16.3M	–	140
2018 Q2	$16.3M	Buy	1,016,980 +7,007	+0.7%	+$99.9K	0.25%	96
2018 Q1	$14.5M	Buy	1,009,973 +30,580	+3%	+$417K	0.29%	80
2017 Q4	$12.8M	Buy	979,393 +464,966	+90%	+$8.36M	0.3%	72
2017 Q3	$9.88M	Buy	+514,427	New	+$11.1M	0.19%	81

Other funds holding NITE

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

WIM

Woodford Investment Management London, United Kingdom $310M AUM 17.41% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

SAM

Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return

TAM

TFG Asset Management Grand Cayman, Cayman Islands $515M AUM 24.47% 1-Year Est. Return

PFM Health Sciences's NITE Position: Q3 2018 in Review

PFM Health Sciences sold out of Nightstar Therapeutics plc American Depositary Shares (NITE) in Q3 2018, closing a stake of 1,016,980 shares — an estimated $16.3M sold.

PFM Health Sciences first reported a position in NITE in Q3 2017 and held it in 4 quarters. The position peaked at $16.3M in Q2 2018. 36 funds tracked by Wall St. Rank hold NITE as of Q3 2018.

PFM Health Sciences reported no remaining Nightstar Therapeutics plc American Depositary Shares position as of Q3 2018 after selling out during the quarter.
PFM Health Sciences sold 1,016,980 Nightstar Therapeutics plc American Depositary Shares shares in Q3 2018, an estimated $16.3M.
PFM Health Sciences first reported a position in Nightstar Therapeutics plc American Depositary Shares in Q3 2017 and held it in 4 quarters.
PFM Health Sciences's Nightstar Therapeutics plc American Depositary Shares position peaked at $16.3M in Q2 2018.
36 funds tracked by Wall St. Rank held Nightstar Therapeutics plc American Depositary Shares as of Q3 2018.

Based on PFM Health Sciences's 13F filing for Q3 2018, filed 13 Nov 2018.